Effects of stratification on data mining in the US Vaccine Adverse Event Reporting System (VAERS)

Drug Safety

Volumn 31, Issue 8, 2008, Pages 667-674

  Woo, Emily Jane ^a,b   Ball, Robert ^a   Burwen, Dale R ^a   Braun, M Miles ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Adverse drug reactions; Adverse reaction monitoring; Data collection; Postmarketing surveillance; Vaccines, adverse reactions

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES RUBELLA VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; TETANUS TOXOID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANAPHYLAXIS; ARTHRITIS; ARTICLE; BRACHIALGIA; BRAIN DISEASE; CHILD; DATA MINING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ENCEPHALITIS; FEMALE; HUMAN; INFANT; INTUSSUSCEPTION; MAJOR CLINICAL STUDY; MALE; NEURITIS; POLIOMYELITIS; PRIORITY JOURNAL; SEX RATIO; THROMBOCYTOPENIC PURPURA; UNITED STATES; VACCINATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; BAYES THEOREM; DATABASES, FACTUAL; HUMANS; MODELS, STATISTICAL; SEX FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VACCINES;

EID: 47649093442     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200831080-00003     Document Type: Article

References (20)

1. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10 (6): 483-6
2. FDA guidance for industry: good pharmacovigilance practices and pharmacoepidemiologic assessment. FDA 2005 Mar [online]. Available from URL: http://www.fda.gov/cder/guidance/6359OCC.htm [Accessed 2008 May 9]
3. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 1999; 53: 177-90
4. Chen RT, Rastogi SC, Mullen JR, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994; 12 (6): 542-50
5. Ellenberg SS, Chen RT. The complicated task of monitoring vaccine safety. Public Health Rep 1997 Jan-Feb; 112 (1): 10-20; discussion 21
6. Varricchio F, Iskander J, Destefano F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004 Apr; 23 (4): 287-94
7. Ball R. Methods of ensuring vaccine safety. Expert Rev Vaccines 2002 Aug; 1 (2): 161-8
8. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 2002; 25 (6): 381-92
9. Niu MT, Erwin DE, Braun MM. Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination. Vaccine 2001; 19 (32): 4627-34
10. McMahon AW, Bryant-Genevier MC, Woo EJ, et al. Photophobia following smallpox vaccination. Vaccine 2005 Jan 19; 23 (9): 1097-8
11. Begier EM, Burwen DR, Haber P, et al. Vaccine Adverse Event Reporting System Working Group. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990-June 2002. Clin Infect Dis 2004 Mar 15; 38 (6): 771-9
12. Woo EJ, Miller NB, Ball R, et al. Adverse events after hepatitis A B combination vaccine. Vaccine 2006 Mar 24; 24 (14): 2685-91
13. Almenoff JS, LaCroix KK, Yuen NA, et al. Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department. Drug Saf 2006; 29 (10): 875-87
14. Almenoff JS, Pattishall EN, Gibbs TG, et al. Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther 2007 Aug; 82 (2): 157-66
15. Banks D, Woo EJ, Burwen DR, et al. Comparing data mining methods on the VAERS database. Pharmacoepidemiol Drug Saf 2005 Sep; 14 (9): 601-9
16. Almenoff J, Tonning JM, Gould AL, et al. Perspectives on the use of data mining in pharmacovigilance. Drug Saf 2005; 28 (11): 981-1007
17. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959 Apr; 22 (4): 719-48
18. Vaccine Safety Committee, Institute of Medicine. Stratton KR, Howe CJ, Johnston RB, editors. Adverse events associated with childhood vaccines: evidence bearing on causality. Washington, DC: National Academy Press, 1994
19. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999 Nov 5; 48 (43): 1007
20. Chan KA, Hauben M. Signal detection in pharmacovigilance: empirical evaluation of data mining tools. Pharmacoepidemiol Drug Saf 2005 Sep; 14 (9): 597-9